Current Atherosclerosis Reports

, Volume 14, Issue 3, pp 187–189 | Cite as

Targeting Cytokine Signaling as an Innovative Therapeutic Approach for the Prevention of Atherosclerotic Plaque Development

Invited Commentary


Tocilizumab Coronary Artery Disease Patient Innate Immune Defense Experimental Mouse Model Infection Susceptibility 



H. Schuett: none; B. Schieffer has received a grant from the German Research Foundation.

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Clinic for Cardiology and AngiologyHannover Medical SchoolHannoverGermany

Personalised recommendations